The link between sarcopenic obesity and Alzheimer's disease: a brain-derived neurotrophic factor point of view
- PMID: 39937973
- DOI: 10.1113/JP288032
The link between sarcopenic obesity and Alzheimer's disease: a brain-derived neurotrophic factor point of view
Abstract
Age-related diseases are becoming more prominent as the lifespan of the global population rises. Many of these diseases coincide with each other and can even influence the onset of additional comorbidities. Sarcopenic obesity is described as age-related loss of muscle mass that concurs with excessive weight gain and tends to increase the risk of comorbidity development, including Alzheimer's disease (AD). Though the exact link between sarcopenic obesity and AD is not known, this review explores the possibility that reduced levels of brain-derived neurotrophic factor (BDNF) throughout the body may serve as the underlying commonality. In AD, reductions in BDNF signalling through its receptor promote the activation of glycogen synthase kinase 3 beta (GSK3β), which subsequently increases the production of amyloid beta (Aβ) peptides and neurofibrillary tangles (NFTs). In the skeletal muscle, lower BDNF concentrations are linked to impaired muscle fibre repair and regeneration, increasing the likelihood of sarcopenia. Furthermore, the absence of BDNF impairs mitochondrial function, leading to insulin resistance and increased adiposity. BDNF concentration has a negative relationship with obesogenic markers in adipose tissue, and as such, lower concentrations of BDNF lead to weight gain. Collectively, current literature suggests that BDNF attenuates AD pathology while improving skeletal muscle mitochondrial function, whole-body insulin resistance and facilitating adipocyte browning. Therefore, BDNF may be a viable target for multiple age-related diseases, but more research is required to substantiate this claim, with a particular focus on examining any potential influence of biological sex, as women are at a higher risk for both AD and sarcopenic obesity.
Keywords: adipose tissue; ageing; brain; crosstalk; skeletal muscle.
© 2025 The Author(s). The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
References
-
- Ahuja, P., Ng, C. F., Pang, B. P. S., Chan, W. S., Tse, M. C. L., Bi, X., Kwan, H. R., Brobst, D., Herlea‐Pana, O., Yang, X., Du, G., Saengnipanthkul, S., Noh, H. L., Jiao, B., Kim, J. K., Lee, C. W., Ye, K., & Chan, C. B. (2022). Muscle‐generated BDNF (brain derived neurotrophic factor) maintains mitochondrial quality control in female mice. Autophagy, 18(6), 1367–1384.
-
- Alizadeh Pahlavani, H., Laher, I., Knechtle, B., & Zouhal, H. (2022). Exercise and mitochondrial mechanisms in patients with sarcopenia. Frontiers in Physiology, 13, 1040381.
-
- Aplin, A. E., Gibb, G. M., Jacobsen, J. S., Gallo, J.‐M., & Anderton, B. H. (1996). In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase‐3β. Journal of Neurochemistry, 67(2), 699–707.
-
- Baranowski, B. J., Hayward, G. C., Marko, D. M., & MacPherson, R. E. K. (2021). Examination of BDNF treatment on BACE1 activity and acute exercise on brain BDNF signaling. Frontiers in Cellular Neuroscience, 15, 665867.
-
- Baranowski, B. J., Mohammad, A., LeBlanc, P. J., Fajardo, V. A., & MacPherson, R. E. K. (2024). Examination of Akt and GSK3beta in BDNF‐mediated reductions in BACE1 activity in neuronal cells. Physiological Reports, 12(16), e70001.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources